-
- Comment in:
-
Mayo Clin Proc. 2008 Jul;83(7):849-50; author reply 850-1.
Oral contraceptive use and risk of breast cancer.
Department of Obstetrics and Gynecology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA. casey.petra@mayo.edu
The clinical impact of the association between oral contraceptive (OC) use and breast cancer risk is important given that OCs are the most commonly prescribed contraceptive agent and that more than a quarter of a million women are diagnosed as having breast cancer in the United States annually. Substantial changes to OC formulations have been made during the past decade, and this review focuses on recent OC trends and risks and benefits. We also have a better understanding of how estrogen affects breast carcinogenesis; research on this topic is ongoing and has the goal of decreasing breast cancer incidence and mortality.
PMID: 18174010 [PubMed - indexed for MEDLINE]
-
Related Articles
-
Patient Drug Information
-
Estrogen (Cenestin®, Enjuvia®, Estrace®, ...)
Estrogen is used to treat hot flushes ('hot flashes'; sudden strong feelings of heat and sweating) in women who are experiencing menopause ('change of life', the end of monthly menstrual periods). Some brands of estroge...